Ignite Creation Date:
2024-05-06 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05023655
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2021-08-12
Brief Title:
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Sponsor:
Prisma Health-Upstate
Organization:
Prisma Health-Upstate
Organization Data
Organization:
Prisma Health-Upstate
Class:
OTHER
Study ID:
EPZ-IST-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Prisma Health-Upstate
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ipsen | INDUSTRY |